Vimarsana
Biggest News Aggregation in the World

Anticancer Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anticancer Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anticancer Fund Today - Breaking & Trending Today

Can Europe afford the next generation of medicines? - Vimarsana News

Can Europe afford the next generation of medicines?

There is a wave of cell and gene therapies in the pipeline, but EU countries will have to deal with hefty price tags.

Forget Moonshot: Cancer Patients Right Now Need 'Groundshot' - Vimarsana News

Forget Moonshot: Cancer Patients Right Now Need 'Groundshot'

While the "Moonshot" aims at the future, a "groundshot" initiative could address the issues facing cancer patients right now by making better use of services that are already available.

Novartis Tafinlar® (dabrafenib) + Mekinist® (trametinib) demonstrates unprecedented efficacy in pediatric patients with BRAF V600 low-grade gliomas in Phase II/III study - Vimarsana News

Novartis Tafinlar® (dabrafenib) + Mekinist® (trametinib) demonstrates unprecedented efficacy in pediatric patients with BRAF V600 low-grade gliomas in Phase II/III study

Treatment with targeted therapies Tafinlar + Mekinist resulted in 47% ORR versus chemotherapy (11%) and reduced risk of progression or death by 69%, showing...